Latent Autoimmune Diabetes in Adults (LADA): What You Need to Know

Latent Autoimmune Diabetes in Adults (LADA), also known as Type 1.5 diabetes, is a form of adult autoimmune diabetes that develops gradually, typically affecting individuals between the ages of 30 and 50. It shares characteristics with both Type 1 diabetes, involving autoimmune destruction of insulin-producing beta cells, and Type 2 diabetes, with its slower progression.

Due to its gradual onset and adult presentation, latent autoimmune diabetes is frequently misdiagnosed as Type 2. Research indicates that between 4% and 12% of adults initially diagnosed with Type 2 diabetes may actually have LADA.

Typical Symptoms

• Excessive thirst and frequent urination
• Unexplained weight loss
• Blurred vision and persistent fatigue

These symptoms closely resemble those seen in both Type 1 and Type 2 diabetes, which often leads to misdiagnosis.

Underlying Cause

Latent Autoimmune Diabetes in Adults (LADA), also known as Type 1.5 diabetes, is caused by the gradual autoimmune destruction of insulin-producing beta cells in the pancreas. Unlike classic Type 1 diabetes, this process unfolds slowly over time, often mimicking the onset of Type 2 diabetes in adults. The presence of autoantibodies (such as GAD) confirms its autoimmune nature.

Management & Treatment

Managing Latent Autoimmune Diabetes in Adults (LADA) involves:

• Early Phase: May briefly respond to oral diabetes medications.
• Progression: Insulin becomes necessary as beta cell function declines.
• Individualized Care: Tailored insulin plans are essential to maintain blood sugar control and prevent complications.

Conclusion

If you or someone you know has been diagnosed with Type 2 diabetes but is not responding to treatment, it’s important to consider Latent Autoimmune Diabetes in Adults (LADA) as a possibility. Speak with your healthcare provider about autoantibody testing to ensure proper diagnosis and tailored treatment.